Literature DB >> 11983686

Control of calcium homeostasis by angiotensin II in adrenal glomerulosa cells through activation of p38 MAPK.

Irina Startchik1, Dominique Morabito, Ursula Lang, Michel F Rossier.   

Abstract

Angiotensin II-induced activation of aldosterone secretion in adrenal glomerulosa cells is mediated by an increase of intracellular calcium. We describe here a new Ca2+-regulatory pathway involving the inhibition by angiotensin II of calcium extrusion through the Na+/Ca2+ exchanger. Caffeine reduced both the angiotensin II-induced calcium signal and aldosterone production in bovine glomerulosa cells. These effects were independent of cAMP or calcium release from intracellular stores. The calcium response to angiotensin II was more sensitive to caffeine than the response to potassium, suggesting that the drug interacts with a pathway specifically elicited by the hormone. In calcium-free medium, calcium returned more rapidly to basal levels after angiotensin II stimulation in the presence of caffeine. Thapsigargin had no effect on these kinetics, but diltiazem, which inhibits the Na+/Ca2+ exchanger, markedly reduced the rate of calcium decrease and abolished caffeine action. The involvement of this exchanger was supported by the effect of cell depolarization and of a reduction of extracellular sodium on the rate of calcium extrusion. We also determined the mechanism of angiotensin II action on the exchanger. Phorbol esters reduced the rate of calcium extrusion, which was increased by baicalein, an inhibitor of lipoxygenases, and by SB 203580, an inhibitor of the p38 MAPK. Finally, we showed that angiotensin II acutely activates, in a caffeine-sensitive manner, p38 MAPK in glomerulosa cells. In conclusion, in bovine glomerulosa cells, the Na+/Ca2+ exchanger plays a crucial role in extruding calcium, and, by reducing its activity, angiotensin II influences the amplitude of the calcium signal. The hormone exerts its action on the exchanger through a caffeine-sensitive pathway involving the p38 MAPK and lipoxygenase products.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983686     DOI: 10.1074/jbc.M110947200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Aldosterone production in human adrenocortical cells is stimulated by high-density lipoprotein 2 (HDL2) through increased expression of aldosterone synthase (CYP11B2).

Authors:  Yewei Xing; Anthony Cohen; George Rothblat; Sandhya Sankaranarayanan; Ginny Weibel; Lori Royer; Omar L Francone; William E Rainey
Journal:  Endocrinology       Date:  2011-01-14       Impact factor: 4.736

2.  Adrenal cell aldosterone production is stimulated by very-low-density lipoprotein (VLDL).

Authors:  Yewei Xing; William E Rainey; John W Apolzan; Omar L Francone; Ruth B S Harris; Wendy B Bollag
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

3.  PERK (eIF2alpha kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis.

Authors:  Shun-Hsin Liang; Wei Zhang; Barbara C McGrath; Peichuan Zhang; Douglas R Cavener
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

4.  Volume-sensitive Cl- current in bovine adrenocortical cells: comparison with the ACTH-induced Cl- current.

Authors:  S Dupré-Aucouturier; A Penhoat; O Rougier; A Bilbaut
Journal:  J Membr Biol       Date:  2004-05-15       Impact factor: 1.843

5.  P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption.

Authors:  Huiren Tao; Mina Okamoto; Masataka Nishikawa; Hideki Yoshikawa; Akira Myoui
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

6.  Effect of developmental NMDAR antagonism with CGP 39551 on aspartame-induced hypothalamic and adrenal gene expression.

Authors:  Kate S Collison; Angela Inglis; Sherin Shibin; Soad Saleh; Bernard Andres; Rosario Ubungen; Jennifer Thiam; Princess Mata; Futwan A Al-Mohanna
Journal:  PLoS One       Date:  2018-03-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.